Colgate Palmolive: Presentation (ecf226)

Consumer Analyst Group of New York Conference

February 20, 2026

© 2026 Colgate-Palmolive Company

February 2026

Notice for Investor Presentation

Please review the following presentation in conjunction with our fourth quarter and full year 2025 earnings press release, our fourth quarter and full year 2025 prepared management remarks and additional information regarding our non-GAAP financial measures, including GAAP to non-GAAP reconciliations, which are available in the Investor Center section of our website at https://www.colgatepalmolive.com/investors and in our fourth quarter and full year 2025 earnings press release. Our presentation contains non-GAAP financial measures, which differ from our reported results prepared in accordance with U.S. generally accepted accounting principles (GAAP). These non-GAAP financial measures of operating results exclude items that, either by their nature or amount, management would not expect to occur as part of the Company's normal business on a regular basis, such as restructuring charges, charges for certain litigation and tax matters, acquisition-related costs, gains and losses from certain divestitures and certain other unusual, non-recurring items. We may also refer to organic sales growth, which is Net sales growth excluding the impact of foreign exchange, acquisitions and divestments, or to free cash flow before dividends, which we define as Net cash provided by operations less Capital expenditures. A complete, quantitative reconciliation between our reported results and these non-GAAP financial measures is available in the Investor Center section of our website at https://www.colgatepalmolive.com and in the tables of our earnings press releases.

Our presentation may contain forward-looking statements (as that term is defined in the U.S. Private Securities Litigation Reform Act of 1995 or by the Securities and Exchange Commission (the SEC) in its rules, regulations and releases) that set forth anticipated results based on management's current plans and assumptions. These statements are made on the basis of our views and assumptions as of February 20, 2026, and we undertake no obligation to update these statements whether as a result of new information, future events or otherwise, except as required by law or by the rules and regulations of the SEC. Moreover, we do not, nor does any other person, assume responsibility for the accuracy and completeness of those statements. We caution investors that forward-looking statements are not guarantees of future performance and actual events or results may differ materially from those statements. For information about factors that could impact the Company's business and cause actual results to differ materially from forward-looking statements, refer to the Company's filings with the SEC (including, but not limited to, the information set forth under the captions "Risk Factors" and "Cautionary Statement on Forward-Looking Statements" in the Company's Annual Report on Form 10-K for the year ended December 31, 2024 and subsequent filings with the SEC). Copies of these filings are available in the Investor Center section of our website at https://www.colgatepalmolive.com.

WITH ME

TODAY

SVP, Global Growth

& Innovation, Hill's Pet Nutrition

Financial review

2025 Full Year Highlights

• Delivered solid results, including increases in net sales, organic sales, Base Business net income and Base Business EPS, despite a very challenging operating environment

• Net sales increased 1.4%; Organic sales* increased 1.4%, including a 0.7% negative impact from lower private label pet volume having exited that non-strategic business

• Organic sales growth was led by strength in oral care and pet nutrition, excluding private label

• Base Business EPS* increased 3%

• Delivered record operating cash flow

• Increased dividends paid per share for the 63rd consecutive year

*Non-GAAP

Our Message Today

1

Our 2025 strategy delivered consistent compounded top and bottom line growth

2

Accelerating change as we execute against our 2030 strategy to drive category growth and market shares

3

Delivering productivity and efficiencies to support our 2030 strategy, fund advertising and drive margin expansion

4

Driving free cash flow to fund investment and drive shareholder value

01

Our 2025 strategy delivered consistent compounded top and bottom line growth

Organic Sales Growth

}

** Guidance*

Long-Term Target Range 3-5%

Non-GAAP

*2026 Guidance: 1% to 4%

**includes a 0.7% negative impact from lower private label pet sales

Growth Across Developed and Emerging Markets

Strong Advertising Spending

Advertising as a % of sales

Driving Accelerated EPS Growth*

Trailing 12 Months EPS

*Non-GAAP / Base Business

/

Delivering Strong TSR

2020 - YTD 2026

1/1/20 through 2/17/26 Proxy Peer Group

02

Accelerating change as we execute against our 2030 strategy to drive category growth and market shares

Accelerating Change for 2030

to Unlock More Growth

Leverage the global reach and penetration of our brands

Build the incremental benefit of superior, science-based innovation

Lead in capabilities like data, analytics and AI

Harness the power of best in class omni-channel demand generation

Evolve our high impact, inclusive culture

Accelerating Change for 2030

to Unlock More Growth

Leverage the global reach and penetration of our brands

Build the incremental benefit of superior, science-based innovation

Lead in capabilities like data, analytics and AI

Harness the power of best in class omni-channel demand generation

Evolve our high impact, inclusive culture

Global Brand Strength

Personal Care

Sources: Worldpanel by Numerator Brand Footprint 2025 and Kantar BrandZ 2025

Global Share Leaders

1

Toothpaste

Manual Toothbrushes

Pet Nutrition in Vet Clinics* (U.S.) Liquid Hand Soap

2

Mouthwash Bar Soap

Liquid Fabric Conditioners Hand Dishwashing

Based on markets where we compete and purchase shares

*Based on IDEXX market share data as of December 31, 2025

Accelerating Change for 2030

to Unlock More Growth

Leverage the global reach and penetration of our brands

Build the incremental benefit of superior, science-based innovation

Lead in capabilities like data, analytics and AI

Harness the power of best in class omni-channel demand generation

Evolve our high impact, inclusive culture

Delivering More Impactful Innovation

Starting With People Centricity

DELIVER PERCEIVABLY SUPERIOR WHITENING

EVOLVING NEED STATES

Admirable Impressions

21% of people want whitening yet 66% of whitening

needs remain unmet